LGND

Ligand Pharmaceuticals Inc

May 15 • 04:00PM ET

213.21

-5.77 -2.63 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: HALO EXEL VKTX ALKS MDGL

| Held by: IJR VTI IWM VB VBR VXF SPSM IJT XSMO IWN

Scroll to Statements

Index	RUT	P/E	28.91	EPS (ttm)	7.38	Insider Own	2.58%	Shs Outstand	20.03M	Perf Week	-3.70%
Market Cap	4.27B	Forward P/E	19.10	EPS next Y	11.16	Insider Trans	-7.73%	Shs Float	19.53M	Perf Month	-4.49%
Enterprise Value	3.95B	PEG	1.15	EPS next Q	2.01	Inst Own	104.46%	Short Float	7.45%	Perf Quarter	15.98%
Income	153.56M	P/S	15.57	EPS this Y	11.35%	Inst Trans	-0.13%	Short Ratio	6.45	Perf Half Y	3.70%
Sales	274.48M	P/B	4.28	EPS next Y	23.30%	ROA	12.60%	Short Interest	1.46M	Perf YTD	12.77%
Book/sh	49.79	P/C	5.48	EPS next 5Y	16.58%	ROE	17.13%	52W High	247.38 -13.81%	Perf Year	106.06%
Cash/sh	38.89	P/FCF	34.71	EPS past 3/5Y	- -	ROIC	10.60%	52W Low	98.89 115.60%	Perf 3Y	174.79%
Dividend Est.	-	EV/EBITDA	29.07	Sales past 3/5Y	10.96% 7.54%	Gross Margin	83.42%	Volatility	3.12% 4.49%	Perf 5Y	155.11%
Dividend TTM	-	EV/Sales	14.37	EPS Y/Y TTM	210.12%	Oper. Margin	36.88%	ATR (14)	10.02	Perf 10Y	181.47%
Dividend Ex-Date	Jul 02, 2010	Quick Ratio	20.95	Sales Y/Y TTM	51.24%	Profit Margin	55.95%	RSI (14)	43.92	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	21.28	EPS Q/Q	69.66%	SMA20	-5.70%	Beta	1.20	Target Price	270.67
Payout	0.00%	Debt/Eq	0.45	Sales Q/Q	14.09%	SMA50	-1.05%	Rel Volume	0.57	Prev Close	218.98
Employees	47	LT Debt/Eq	0.45	Earnings	May 07 BMO	SMA200	11.40%	Avg Volume	225.50K	Price	213.21
IPO	Nov 18, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	-10.23% -11.88%	Trades		Volume	127,863	Change	-2.63%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)